v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balances, at Beginning of period at Dec. 31, 2024 $ 1,057 $ 422,047 $ (216,853) $ 206,251
Balances, at Beginning of period, Shares at Dec. 31, 2024 105,711,093      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense   3,039   3,039
Exercise of stock options $ 3 380   383
Exercise of stock options, shares 290,993      
Vesting of restricted stock units $ 3 (3)    
Vesting of restricted stock units, shares 311,632      
Net loss     (10,261) (10,261)
Balances, at end of period at Mar. 31, 2025 $ 1,063 425,463 (227,114) 199,412
Balances, at end of period, Shares at Mar. 31, 2025 106,313,718      
Balances, at Beginning of period at Dec. 31, 2025 $ 1,068 431,905 (261,483) 171,490
Balances, at Beginning of period, Shares at Dec. 31, 2025 106,789,618      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation expense   1,141   1,141
Exercise of stock options   5   5
Exercise of stock options, shares 4,814      
Vesting of restricted stock units $ 3 (3)    
Vesting of restricted stock units, shares 327,240      
Net loss     (4,750) (4,750)
Balances, at end of period at Mar. 31, 2026 $ 1,071 $ 433,048 $ (266,233) $ 167,886
Balances, at end of period, Shares at Mar. 31, 2026 107,121,672